CaverMap

CaverMap

Urology A device that maps and locates the cavernosal nerve filaments during radical prostatectomy, helping preserve the nerve bundles, when feasible, in an attempt to maintain Pt potency and continence. See Prostate cancer, Radical prostatectomy.
References in periodicals archive ?
CaverMap may have some role for training programs and for the occasional surgeon, but I do not think it has been a major adjunct, at least with the present design.
This new technology, the CaverMap Surgical Aid, is the first electronic device designed to assist urologic surgeons in identifying and mapping the course of erectile function nerves during prostate surgery.
s new CaverMap, unveiled Thursday, is similar to a metal detector: The closer the surgeon's knife gets to a nerve, the faster the machine beeps in warning.
The Company is pursuing various options to improve its cash position, including the possible sale of equity securities, and the divestiture of its Cavermap assets and technology.
UroMed's direct hospital-based business lines include its CaverMap Surgical Aid, intended to aid physicians in preserving vital nerves during prostate cancer surgery, its Iodine-125 prostate cancer brachytherapy seeds (not yet commercially available), its brachytherapy introducer needles, and its AlloSling and BEACON Technology System minimally invasive incontinence surgical lines.
The Company recognizes that the previous paragraphs contain forward-looking statements relating to the Company's future activities, including the benefits expected through the Company's combination with SSGI, the development and commercialization of the SSGI product line and the company's CaverMap Surgical Aid and Symmetra I-125 radioactive seeds, the Company's anticipated sequential improvement in operating performance in the first quarter of 2001 and future growth.
multicenter clinical studies with six leading prostate cancer surgeons to evaluate and quantify the benefits to patients and surgeons of utilizing the CaverMap Surgical Aid.
As a result of the combination of the business of UroMed and SSGI, the new company will seek to market a portfolio of products including: the Symmetra I-125 radioactive seeds, used in brachytherapy procedures to treat localized prostate cancer, the CaverMap Surgical Aid, available to aid physicians in preserving vital nerves during prostate cancer surgery; brachytherapy introducer needles; Prosim - SSGI/Prowess product platform for 3D external beam cancer treatment, and the BrachyPro - SSGI/Prowess brachytherapy treatment planning system.
4 million in comparing the fourth quarter of 2000 to the third quarter of 2000, we anticipate strong revenue growth in 2001 as a result of the combined company offering Symmetra, CaverMap and the SSGI product lines.
CaverMap (R) Surgical Aid is a registered trademark of UroMed Corporation and Symmetra (TM) I-125 Seeds is a trademark of UroMed Corporation.
Our CaverMap business maintained stability during the quarter even though the focus of our sales and marketing efforts shifted to our Symmetra product.
Impress Softpatch, PelvicFlex Personal Trainer Video, BEACON Technology System, BreastCheck, BreastExam and CaverMap Surgical Aid are trademarks of UroMed Corporation.